Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
Jim Cramer: Reddit Is 'Fabulous,' Dow Is A 'Tough' One
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.On CNBC's "Mad Money Lightning Round," Jim Cramer said Reddit, Inc. (NYSE:RDDT) is "fabulous," adding that he is not a seller.
在CNBC的"疯狂金钱闪电轮"节目中，吉姆·克莱默表示Reddit公司（纽交所：RDDT）"棒极了"，并补充说他不是卖家。
According to a report last week, shareholder Advance Magazine Publishers, Inc. plans to establish a credit facility using its stake in the company. Yahoo Finance reported that the publishing company aims to make as much as $1.2 billion in a sale of 7.8 million shares for between $145.38 and $148.54 per share.
根据上周的一份报告，股东Advance Magazine Publishers公司计划利用其在公司的股份设立一项信贷额度。《雅虎财经》报道称，这家出版公司计划以每股145.38美元至148.54美元的价格出售780万股，最多可获得12亿美元。
"I am concerned that many auto parts may be made in China, we don't know," Cramer said when asked about Aptiv PLC (NYSE:APTV). He recommended going with AutoZone (NYSE:AZO).
"我担心许多汽车零件可能是在中国制造的，我们不知道，"克莱默在被问及Aptiv PLC（纽交所：APTV）时表示。他建议选择汽车零部件公司（纽交所：AZO）。
On Nov. 21, Guggenheim analyst Ronald Jewsikow maintained Aptiv with a Buy and lowered the price target from $87 to $73.
11月21日，古根海姆分析师罗纳德·尤西考维维维维维维平Aptiv的评级为买入，并将目标价从87美元降至73美元。
When asked about Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), he said, "Now, I think, at five, it's, it is worthwhile speculation."
在被问及Recursion Pharmaceuticals公司（纳斯达克：RXRX）时，他表示，“现在，我认为，在五美元的时候，这是值得的投机。”
On Nov. 20, Needham analyst Gil Blum reiterated Recursion Pharmaceuticals with a Buy and maintained a price target of $11.
11月20日，Needham分析师吉尔·布卢姆重申了Recursion Pharmaceuticals的买入评级，并维持了11美元的目标价。
"Not enough specialty," Cramer said when asked about ZoomInfo Technologies Inc. (NASDAQ:ZI). "Let's pass on that."
"关于ZoomInfo Technologies公司（纳斯达克：ZI），克莱默表示，"没有足够的特色。"我们不要关注这个。"
On Nov. 12, ZoomInfo Technologies reported better-than-expected earnings for its third quarter.
11月12日，ZoomInfo Technologies公司报告了其第三季度超过预期的收益。
Dow Inc. (NYSE:DOW) is a "tough" one, the "Mad Money" host said. "If you don't have growth, and you sell at 21 times earnings, you're not going to be able to do anything."
陶氏化学（NYSE:DOW）是一个"棘手"的情况，"疯狂金钱"主持人表示。"如果你没有增长，并且以21倍的收益率卖出，你就不会有任何作为。"
On Nov. 8, Piper Sandler analyst Charles Neivert maintained Dow with an Overweight rating and lowered the price target from $62 to $60.
11月8日，派杰投资分析师查尔斯·内弗特（Charles Neivert）维持陶氏化学为超配评级，并将价格目标从62美元降至60美元。
Cramer said, "Accounting irregularities equal sell," when asked about Super Micro Computer (NASDAQ:SMCI).
克莱默表示，"会计不正常等于卖出"，当被问及超微电脑（NASDAQ:SMCI）时。
Super Micro Computer experienced a significant stock decline on Tuesday, after announcing the termination of two critical loan agreements with major financial institutions.
超微电脑周二经历了一次重大股票下跌，宣布与主要金融机构终止两项关键贷款协议后。
Price Action:
价格行动：
- Aptiv shares fell 3.2% to settle at $55.28 on Tuesday.
- Reddit shares fell 4.4% to close at $135.61.
- Recursion Pharmaceuticals shares declined 1.8% to close at $5.89.
- ZoomInfo shares gained 0.2% to close at $10.89.
- Dow shares fell 2.9% to settle at $44.54 on Tuesday.
- Super Micro Computer shares dipped 10.4% to settle at $34.43 during the session.
- Aptiv股价周二下跌3.2%，收于55.28美元。
- Reddit股价下跌4.4%，收于135.61美元。
- Recursion Pharmaceuticals股价下跌1.8%，收于5.89美元。
- zoominfo股价上涨0.2%，收盘价为$10.89。
- 陶氏化学股价下跌2.9%，周二收于$44.54。
- 超微电脑股价下跌10.4%，收于$34.43。
- Jim Cramer: Linde Is A 'Terrific' Company, Sees Another Stock Up 75% As 'Not Done'
- 吉姆·克莱默：linde是一家“优秀”的公司，认为另一只股票上涨75%还“没有结束”
Photo: Shutterstock
Photo: shutterstock
译文内容由第三方软件翻译。
